Background This study was designed to determine the impact of positive margin and
neoadjuvant chemotherapy (NAC) on recurrence and survival after resection of colorectal …

Background Survival with long-term follow-up following liver resection for unresectable
colorectal liver metastases (CRLM) downsized by chemotherapy has rarely been reported …

Background The aim of this study was to investigate the influence of resection margin status
in patients with KRAS mutations (mt-KRAS) when compared to those with wild-type KRAS …

Background: This study aims to develop a nomogram to predict early recurrence in
colorectal liver metastases (CRLM) patients who received neoadjuvant chemotherapy …

Introduction: Surgery is the only potentially curative treatment for patients with colorectal liver
metastases, resulting in 5-year survival rates of 36-58. Although many studies have been …

BACKGROUND: Portal vein embolization (PVE) is an effective procedure to increase the
future remnant liver (FRL) before major hepatectomy. A controversial issue is that PVE may …

Background Varying definitions of resection margin clearance are currently employed
among patients with colorectal cancer liver metastases (CRLM). Specifically, a …

As for resection for colorectal liver metastasis (CRLM), securing an adequate surgical
margin is important for achieving a better prognosis. However, it is often difficult to achieve …

Background A potentially favorable effect of chemotherapy on the incidence of
micrometastases has been reported in patients with colorectal liver metastases (CLMs); …

Despite improved overall survival rates after potentially curative liver resection (∼ 50–58%
at 5 years), almost half of patients experience disease recurrence highlighting the need for a …